+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevalence of gastro-oesophageal reflux disease with upper gastrointestinal symptoms without heartburn and regurgitation



Prevalence of gastro-oesophageal reflux disease with upper gastrointestinal symptoms without heartburn and regurgitation



United European Gastroenterology Journal 2(3): 173-178



Symptomatically 'silent' gastro-oesophageal reflux disease (GORD) may be underdiagnosed. To determine the prevalence of untreated GORD without heartburn and/or regurgitation in primary care. Patients were included if they had frequent upper gastrointestinal symptoms and had not taken a proton pump inhibitor in the previous 2 months (Diamond study: NCT00291746). GORD was diagnosed based on the presence of reflux oesophagitis, pathological oesophageal acid exposure, and/or a positive symptom-acid association probability. Patients completed the Reflux Disease Questionnaire (RDQ) and were interviewed by physicians using a prespecified symptom checklist. GORD was diagnosed in 197 of 336 patients investigated. Heartburn and/or regurgitation were reported in 84.3% of patients with GORD during the physician interviews and in 93.4% of patients with GORD when using the RDQ. Of patients with heartburn and/or regurgitation not identified at physician interview, 58.1% (18/31) reported them at a 'troublesome' frequency and severity on the RDQ. Nine patients with GORD did not report heartburn or regurgitation either at interview or on the RDQ. Structured patient-completed questionnaires may help to identify patients with GORD not identified during physician interview. In a small proportion of consulting patients, heartburn and regurgitation may not be present in those with GORD.

(PDF emailed within 0-6 h: $19.90)

Accession: 055157943

Download citation: RISBibTeXText

PMID: 25360300

DOI: 10.1177/2050640614532458


Related references

Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 38(10): 1303-1311, 2014

The prevalence of upper respiratory symptoms in a cohort of adults presenting with symptoms of gastro-oesophageal reflux disease. Ceylon Medical Journal 61(2): 63-67, 2016

Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 13(12): 1621-1630, 1999

Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux disease patients treated with a proton-pump inhibitor. Alimentary Pharmacology & Therapeutics 18(1): 133-140, 1st July, 2003

Can acid pocket-targeting alginate-antacid (Gaviscon Double Action) relieve upper gastrointestinal symptoms in gastro-oesophageal reflux disease?. Korean Journal of Gastroenterology 63(6): 386-388, 2016

Prevalence of gastro-oesophageal reflux disease symptoms and reflux-associated respiratory symptoms in asthma. Bmc Pulmonary Medicine 10(): 49-49, 2011

Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 21 Suppl 2: 2-9, 2005

Severe symptoms of gastro-oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: a population-based study. Alimentary Pharmacology & Therapeutics 27(1): 58-65, 2007

Severe symptoms of gastro-oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but. 2008

High prevalence of reflux symptoms in duodenal ulcer patients who develop gastro-oesophageal reflux disease after curing Helicobacter pylori infection. Digestive and Liver Disease 33(8): 665-670, 2002

The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Alimentary Pharmacology & Therapeutics 16(9): 1655-1662, September, 2002

Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Annals of Medicine 27(1): 67-70, 1995

Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms. Digestive and Liver Disease 44(12): 1032-1036, 2013

Is motility impaired in the entire upper gastrointestinal tract in patients with gastro-oesophageal reflux disease?. Scandinavian Journal of Gastroenterology 31(2): 131-135, 1996

Systematic review: ageing and gastro-oesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis. Alimentary Pharmacology & Therapeutics 33(4): 442-454, 2011